CVSA Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Strong Profitability And Cash GenerationCVSA combines strong operating margins with meaningful profitability and substantial free cash flow. This earnings and cash-generation base can support ongoing investment, debt service, and strategic initiatives while providing resilience across the next several quarters.
Healthy Growth TrajectoryPositive revenue growth alongside faster EPS expansion indicates that CVSA is increasing scale while converting growth into improving per-share earnings. Continued operating leverage or disciplined cost management could reinforce earnings momentum over the medium term.
Healthcare Education ExpansionThe Nashville launch extends Chamberlain’s geographic footprint and aligns its programs with a stated healthcare workforce shortage. A new campus and flexible scheduling can broaden student access and create an additional platform for enrollment growth over time.
Bears Say
Historical Margin VolatilityAlthough current profitability is strong, the prior loss and recent net-margin step-down show that earnings conversion has not been consistently stable. Higher costs or reinvestment needs could pressure profitability again if revenue growth moderates.
Rising Debt And Leverage HistoryModerate leverage remains manageable, but rising absolute debt and previously higher leverage reduce financial flexibility if operating performance weakens. Debt obligations may constrain capital allocation and increase sensitivity to future profitability changes.
Mixed Cash-flow ConversionStrong current free cash flow is partly offset by weaker operating-cash-flow conversion and a history of negative free cash flow. Working-capital timing, cyclicality, or investment spikes could therefore make internally generated cash less predictable.
Covista News
CVSA FAQ
What was Covista’s price range in the past 12 months?
Currently, no data Available
What is Covista’s market cap?
Covista’s market cap is CHF3.46B.
When is Covista’s upcoming earnings report date?
Covista’s upcoming earnings report date is Oct 29, 2026 which is in 27 days.
How were Covista’s earnings last quarter?
Covista released its earnings results on Aug 06, 2026. The company reported CHF1.738 earnings per share for the quarter, beating the consensus estimate of CHF1.573 by CHF0.165.
Is Covista overvalued?
According to Wall Street analysts Covista’s price is currently Undervalued.
Does Covista pay dividends?
Covista does not currently pay dividends.
What is Covista’s EPS estimate?
Covista’s EPS estimate is 1.52.
How many shares outstanding does Covista have?
Currently, no data Available
What happened to Covista’s price movement after its last earnings report?
Covista reported an EPS of CHF1.738 in its last earnings report, beating expectations of CHF1.573. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Covista?
Currently, no hedge funds are holding shares in CH:CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF133.41 (― Downside)
CHF133.41 (― Downside)
Blogger Sentiment
Bullish
CH:CVSA Sentiment 89%
Sector Average 64%
Sector Average 64%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
13.76%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Covista
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
CVSA Company Deck
CVSA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: enrollment growth across institutions, improved margins (when adjusting for a one-week timing shift), raised revenue and EPS guidance, robust free cash flow, balance sheet improvement, share repurchases, campus expansion plans, and technology/AI initiatives. Near-term headwinds include an $18M timing impact at Walden that masked stronger underlying results, modest absolute enrollment improvement at Chamberlain this quarter (0.5%), continued investment-driven CapEx and strategic spending, and an expected higher effective tax rate. Overall, the positives (organic growth, margin expansion excluding timing, raised guidance, cash generation, and clear remediation at Chamberlain) outweigh the transitory and execution-related challenges noted.View all CH:CVSA earnings summariesCVSA Stock 12 Month Forecast
Average Price Target
CHF133.41
American Public Education
―
Perdoceo Education
―
Grand Canyon Education
―
Stride
―
Strategic Education
―